Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review

NA Sutedja, JH Veldink, K Fischer… - Amyotrophic Lateral …, 2009 - Taylor & Francis
Environmental exposure to chemicals and metals may contribute to the risk of sporadic
amyotrophic lateral sclerosis (ALS). Two systematic reviews of the literature on these topics …

Physical activity and the association with sporadic ALS

JH Veldink, S Kalmijn, GJ Groeneveld, MJ Titulaer… - Neurology, 2005 - AAN Enterprises
Objective: To assess whether lifetime physical activity during work and leisure time is
associated with an increased risk of developing ALS and to determine the association between …

Multifocal motor neuropathy

JTH Van Asseldonk, H Franssen… - The Lancet …, 2005 - thelancet.com
Multifocal motor neuropathy (MMN) is an immune-mediated disorder characterised by
slowly progressive, asymmetrical weakness of limbs without sensory loss. The clinical …

Periventricular lesions in the white matter on magnetic resonance imaging in the elderly: a morphometric correlation with arteriolosclerosis and dilated perivascular …

JC Swieten, JHWVANDEN HOUT, BAVAN KETEL… - Brain, 1991 - academic.oup.com
Magnetic resonance imaging (MRI) was performed postmortem on the brains of 40 patients
aged over 60 yrs who had died from causes other than brain disease. Periventricular lesions …

Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling

M Ausems, J Verbiest, MMP Hermans… - European Journal of …, 1999 - nature.com
Glycogen storage disease type II (GSD II) is an autosomal recessive myopathy. Early and
late-onset phenotypes are distinguished–infantile, juvenile and adult. Three mutations in the …

Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis

MA Van Es, JH Veldink, CGJ Saris, HM Blauw… - Nature …, 2009 - nature.com
We conducted a genome-wide association study among 2,323 individuals with sporadic
amyotrophic lateral sclerosis (ALS) and 9,013 control subjects and evaluated all SNPs with P < …

A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis

GD Borasio, W Robberecht, PN Leigh, J Emile… - Neurology, 1998 - AAN Enterprises
To test the safety and efficacy of recombinant human insulin-like growth factor-I (rhIGF-I) in
ALS, 183 patients from eight European centers were randomized to receive double-blind …

Polymyositis: an overdiagnosed entity

MFG van der Meulen, IM Bronner, JE Hoogendijk… - Neurology, 2003 - AAN Enterprises
Background: According to widely used criteria (Bohan and Peter criteria, 1975), dermatomyositis
(DM) is differentiated from polymyositis (PM) only by skin changes. More recent criteria …

A randomized sequential trial of creatine in amyotrophic lateral sclerosis

G Jan Groeneveld, JH Veldink… - Annals of Neurology …, 2003 - Wiley Online Library
Amyotrophic lateral sclerosis (ALS) is a fatal disease with no cure. In a transgenic mouse
model of ALS, creatine monohydrate showed a promising increase in survival. We performed a …

Diagnostic value of high-resolution sonography in ulnar neuropathy at the elbow

R Beekman, MC Schoemaker, JPL Van Der Plas… - Neurology, 2004 - AAN Enterprises
Objective: To determine the diagnostic value of high-resolution sonography in ulnar neuropathy
at the elbow (UNE). Methods: Sonographic ulnar nerve diameter measurement was …